patient centricity

ACRES Announces Appointment of Pamela Duffy of Pfizer as New Board Chairperson

The Alliance for Clinical Research Excellence and Safety (ACRES) announces the appointment of Pamela Duffy of Pfizer as new Board Chairperson, leading the development and implementation of a Strategic Plan for ACRES second decade.   NOBLEBORO, MAINE (PRWEB) SEPTEMBER 16, 2021 The Alliance for Clinical Research Excellence and Safety (ACRES), a US-based non-profit global collaborative…

Free Real-World Data Tool Launched to Battle COVID-19

ACRP Blog – April 28, 2020   The Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based global nonprofit collaborative, is distributing a simple online tool for collection and analysis of real-world data (RWD) on predisposing conditions, treatment strategies, outcomes, and side effects experienced by COVID-19 patients. The survey tool, designed by Veracuity LLC,…

ACRES Unveils Global Quality Standard for Clinical Research Site Accreditation

The Alliance for Clinical Research Excellence and Safety (ACRES), a multi-stakeholder non-profit public-interest collaborative building a comprehensive global system to accelerate medicines development, has released for public review and comment the first global quality standard for clinical research sites, creating a foundation for voluntary accreditation.   CAMBRIDGE, MASS. (PRWEB) JULY 17, 2018 The Alliance for…

NEJM: Accreditation of Clinical Research Sites — Moving Forward

Perspective Accreditation of Clinical Research Sites — Moving Forward NEJM 27 June 2018 Greg Koski, Ph.D., M.D., Larry Kennedy, Ph.D., Mary F. Tobin, Ph.D. and Matthew Whalen, Ph.D. ARTICLE Metrics 5 References Accreditation is used in many fields, including education, travel, construction, and health care. When implemented correctly, it improves quality, performance, and safety, while signaling to the…

ACRES and EXOCHAIN To Accelerate Clinical Research with LYNK BLOCKCHAIN Protocol

The Alliance for Clinical Research Excellence and Safety® signs Agreement with EXOCHAIN™ to Provide Blockchain Technology in Support of Patient and Physician Secure Identity in Clinical Trials. EXOCHAIN CEO and co-founder, Bob Stewart: “Success… depends on trust, accessibility, and immutability of shared data and transparency. This is a perfect use case for EXOCHAIN’s LYNK utility…

ACRES to Launch Innovative Patient Empowerment Initiative for Biomedical Research

CAMBRIDGE, MASS. (PRWEB) DECEMBER 19, 2017 Dr. Greg Koski, President and CEO of the Alliance for Clinical Research Excellence and Safety (ACRES), announced today the roll-out of the ACRES Patient Empowerment Initiative, aligning diverse stakeholders across the clinical research community—including patients, regulators, pharmaceutical companies, research sites, contract research organizations, suppliers, ethics committees—to integrate multiple efforts…

ACRES and BSI Launch Global Working Party to Develop Standards for Clinical Research Sites

The Alliance for Clinical Research Excellence and Safety (ACRES), in partnership with the British Standards Institution (BSI), has launched a multi-stakeholder global working party to fast-track development of standards for all aspects of site work, laying the foundation for recognizing and rewarding excellence at clinical research sites worldwide and accelerating development of safe and effective…

Former Sonavation Chief Robert Stewart to Lead ACRES Global IT Initiatives

Robert E. Stewart, Sr. joins the Alliance for Clinical Research Excellence and Safety (ACRES) as Chief Technology Officer and Board member. He will lead the development and implementation of ACRES shared global system IT infrastructure, generating “smart tools” to radically alter the conduct of biomedical research. CAMBRIDGE, MA (PRWEB) APRIL 05, 2016 The Alliance for Clinical…

Exploring Patient-Centricity from a Patient’s Perspective

OperationsClinical Trials Arena Staff Writer 16:44, December 1 2015 Cancer survivor and patient advocate, Jack Whelan, explores what it really takes for clinical trials to be “patient-centric”  As a seven-year survivor of a rare form of cancer, former IT Research Analyst and now patient advocate, Jack Whelan knows a thing or two about clinical trials….